Pacira BioSciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PCRX and other ETFs, options, and stocks.

About PCRX

Pacira Biosciences, Inc. is a holding company, which engages in the provision of non-opioid pain management and regenerative health solutions to improve patients’ journeys along the neural pain pathway. Its products include EXPAREL, iovera, and DepoFoam. 

CEO
Frank D. Lee
CEOFrank D. Lee
Employees
790
Employees790
Headquarters
Tampa, Florida
HeadquartersTampa, Florida
Founded
2006
Founded2006
Employees
790
Employees790

PCRX Key Statistics

Market cap
1.02B
Market cap1.02B
Price-Earnings ratio
52.95
Price-Earnings ratio52.95
Dividend yield
Dividend yield
Average volume
946.58K
Average volume946.58K
High today
$23.98
High today$23.98
Low today
$22.01
Low today$22.01
Open price
$23.54
Open price$23.54
Volume
483.58K
Volume483.58K
52 Week high
$27.64
52 Week high$27.64
52 Week low
$16.00
52 Week low$16.00

Stock Snapshot

Pacira BioSciences(PCRX) stock is priced at $23.78, giving the company a market capitalization of 1.02B. It carries a P/E multiple of 52.95.

As of 2025-11-14, Pacira BioSciences(PCRX) stock has fluctuated between $22.01 and $23.98. The current price stands at $23.78, placing the stock +8.0% above today's low and -0.8% off the high.

The Pacira BioSciences(PCRX)'s current trading volume is 483.58K, compared to an average daily volume of 946.58K.

In the last year, Pacira BioSciences(PCRX) shares hit a 52-week high of $27.64 and a 52-week low of $16.00.

In the last year, Pacira BioSciences(PCRX) shares hit a 52-week high of $27.64 and a 52-week low of $16.00.

PCRX News

Simply Wall St 1d
Pacira BioSciences' Strong Earnings Are Of Good Quality

When companies post strong earnings, the stock generally performs well, just like Pacira BioSciences, Inc.'s ( ) stock has recently. We did some digging and fou...

Pacira BioSciences' Strong Earnings Are Of Good Quality
TipRanks 7d
Pacira BioSciences Reports Strong Q3 Growth Amid Challenges

Pacira ((PCRX)) has held its Q3 earnings call. Read on for the main highlights of the call. Meet Your ETF AI Analyst Discover how TipRanks' ETF AI Analyst can h...

Analyst ratings

50%

of 6 ratings
Buy
50%
Hold
33.3%
Sell
16.7%

People also own

Based on the portfolios of people who own PCRX. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.